Work

A Single-Arm, Open-Label, Multi-Center Phase I/II Study Of The Combination Of Panobinostat and Carfilzomib In Patients (pts) With Relapsed Or Relapse/Refractory Multiple Myeloma (MM)

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.1937.1937

Authors: Jesus Berdeja, Michael Savona, Joseph R Mace, Lowell Hart, James Essell, Rami Owera, Edward Arrowsmith, Ian Flinn

Institutions: Sarah Cannon, Tennessee Oncology, Florida Cancer Specialists & Research Institute, Oncology Hematology Care

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2292115641

FWCI: 1.9

Cites:

Cited by: 8

Related to: 10